On October 7, 2019 Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense reported that Kineta has been invited to participate at multiple investor conferences in October 2019 (Press release, Kineta, OCT 7, 2019, View Source [SID1234540097]). Shawn Iadonato, Kineta Chief Executive Officer, and members of the executive management team will provide a corporate overview at the following conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Solebury Trout Private Company Showcase
Friday, October 18, 2019 at 10:00AM Eastern time at Davis Polk & Wardwell, LLP in New York

BIO Investor Forum
Tuesday, October 22, 2019 at 10:00AM Pacific time at The Westin St. Francis in San Francisco, CA

Family Office & Private Wealth Management Forum West
Thursday, October 24, 2019 at 12:20PM Pacific time at the Napa Valley Marriott Hotel & Spa in Napa, CA